OA02.03 Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6
2018 ◽
Vol 13
(10)
◽
pp. S322-S323
◽
S. Ou
◽
A. Shaw
◽
G. Riely
◽
R. Chiari
◽
J. Bauman
◽
...
Sam Janes
◽
Laura Succony
2021 ◽
Vol 16
(3)
◽
pp. S651-S652
J. Beal
◽
D. Gomes
◽
P. Taranto
◽
L. Koch
◽
A.C. Rezende
◽
...
Ying Cheng
◽
Qiming Wang
◽
Kai Li
◽
Jianhua Shi
◽
Ying Liu
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S646
◽
C. Ocampo
◽
J. Wu
◽
J. Dey
◽
Z. Sun
◽
M. Motwani
◽
...
2012 ◽
Vol 76
(1)
◽
pp. 78-83
◽
Benjamin Besse
◽
David Planchard
◽
Anne-Sophie Veillard
◽
Laurent Taillade
◽
David Khayat
◽
...
2015 ◽
Vol 93
(4)
◽
pp. 757-764
◽
Gregory M.M. Videtic
◽
Chen Hu
◽
Anurag K. Singh
◽
Joe Y. Chang
◽
William Parker
◽
...
2014 ◽
Vol 25
◽
pp. iv515
Y. Tsukita
◽
N. Morikawa
◽
S. Sugawara
◽
M. Maemondo
◽
T. Harada
◽
...
2019 ◽
Vol 20
(2)
◽
pp. 134-138
◽
Takashi Ninomiya
◽
Nobuhisa Ishikawa
◽
Koji Inoue
◽
Toshio Kubo
◽
Masayuki Yasugi
◽
...
J. Liang
◽
W. Wang
◽
G. Ou
◽
Z. Hui
◽
J. Lv
◽
...